This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2004
Title: Jean-Pierre Falgueyret: Innovator in Cysteine Protease Inhibitors
Introduction
Jean-Pierre Falgueyret is a notable inventor based in Rigaud, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit cysteine proteases. His work is particularly relevant in the context of treating diseases such as osteoporosis.
Latest Patents
Falgueyret holds a patent for a novel class of compounds known as Cathepsin cysteine protease inhibitors. This invention focuses on inhibitors of Cathepsins K and L, which are crucial for managing bone resorption. The patent highlights the potential of these compounds in treating conditions where bone resorption inhibition is necessary.
Career Highlights
Throughout his career, Falgueyret has demonstrated a commitment to advancing medical science through innovative research. His work has implications for improving the quality of life for individuals suffering from bone-related diseases. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.
Collaborations
Falgueyret has collaborated with esteemed colleagues such as Osamu Okamoto and Robert M Rydzewski. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
Jean-Pierre Falgueyret's contributions to the field of cysteine protease inhibitors represent a significant advancement in medical research. His innovative work continues to pave the way for new treatments for diseases like osteoporosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile